Listen to an audio podcast of the September 12th, 2024 FDA Drug Safety Communication on rare occurrence of serious liver injury with use of Veozah (fezolinetant) for hot flashes due to menopause.
Similar Posts
Firehook of Virginia Issues Allergy Alert on Undeclared Sesame in Classic Sea Salt Crackers

Effective Blog Promotion: Strategies to Increase Your Reach
Introduction A key aspect of successful blogging is not just creating great content, but also effectively promoting it. This post will explore various strategies to increase the visibility and reach of your blog. 1. Leverage Social Media Platforms Utilize different social media platforms to promote your blog posts. Tailor your approach for each platform to…

The Essentials of Blogging: Tips and Strategies for Success
Introduction Welcome to the world of blogging! Whether you’re a beginner looking to start your journey or an experienced blogger aiming to enhance your skills, this post is designed to provide valuable insights and strategies for successful blogging. Blogging is not just about writing; it’s an art that involves engaging your audience, sharing your knowledge,…
Serious liver injury being observed in patients without cirrhosis taking Ocaliva (obeticholic acid) to treat primary biliary cholangitis
Decision: Medicines: new manufacturing and wholesale dealer licences
List of sites granted a manufacturer or wholesale dealer licence.